MetaADEDB 2.0 @ LMMD
Tapentadol
(ZELFLGGRLLOERW-YECZQDJWSA-N)
Structure
SMILES
CC[C@@H](c1cccc(c1)O)[C@H](CN(C)C)C.Cl
Molecular Formula:
C14H24ClNO
Molecular Weight:
257.799
Log P:
3.8855
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
2
TPSA:
23.47
CAS Number(s):
175591-09-0
Synonym(s)
1.
Tapentadol
2.
3-((1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl)phenol
3.
Nucynta
4.
Tapentadol Hydrochloride
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 114
Canada Vigilance: 1
Canada Vigilance
US FAERS
2Drug dose omissionFAERS: 64US FAERS
3Adverse eventFAERS: 49US FAERS
4SomnolenceFAERS: 49US FAERS
5NauseaFAERS: 45US FAERS
6PainFAERS: 41US FAERS
7HeadacheFAERS: 37US FAERS
8DizzinessFAERS: 35US FAERS
9OverdoseFAERS: 25US FAERS
10DeliriumFAERS: 24US FAERS
11Drug withdrawal syndromeFAERS: 24US FAERS
12Suicide attemptFAERS: 24US FAERS
13Serotonin SyndromeFAERS: 23US FAERS
14Urinary RetentionFAERS: 21US FAERS
15MalaiseFAERS: 20US FAERS
16Product distribution issueFAERS: 20US FAERS
17Accidental exposure to product by childFAERS: 19US FAERS
18Drug dose titration not performedFAERS: 19US FAERS
19Product use in unapproved indicationFAERS: 19US FAERS
20AnxietyFAERS: 17US FAERS
21Drug prescribing errorFAERS: 17US FAERS
22PruritusFAERS: 17US FAERS
23TachycardiaFAERS: 17US FAERS
24Product quality issueFAERS: 16US FAERS
25VomitingFAERS: 16US FAERS
26Feeling abnormalFAERS: 15US FAERS
27FatigueFAERS: 14US FAERS
28PalpitationsFAERS: 14US FAERS
29TremorFAERS: 14US FAERS
30Chest PainFAERS: 13US FAERS
31ConstipationFAERS: 13US FAERS
32Malignant neoplasm progressionFAERS: 13US FAERS
33Product dose omissionFAERS: 13US FAERS
34Toxicity to various agentsFAERS: 12US FAERS
35AgitationFAERS: 10US FAERS
36Drug screen positiveFAERS: 10US FAERS
37HypersensitivityFAERS: 10US FAERS
38HypotensionFAERS: 10US FAERS
39Abdominal PainFAERS: 9US FAERS
40AmnesiaFAERS: 9US FAERS
41Cerebrovascular accidentFAERS: 8US FAERS
42Drug abuseFAERS: 8US FAERS
43IleusFAERS: 8US FAERS
44Inappropriate schedule of drug administrationFAERS: 8US FAERS
45Incorrect dose administeredFAERS: 8US FAERS
46LethargyFAERS: 8US FAERS
47Accidental exposure to productFAERS: 7US FAERS
48Chest discomfortFAERS: 7US FAERS
49DisorientationFAERS: 7US FAERS
50Drug administration errorFAERS: 7US FAERS
51RestlessnessFAERS: 7US FAERS
52SyncopeFAERS: 7US FAERS
53Unevaluable eventFAERS: 7US FAERS
54AsthmaFAERS: 6US FAERS
55Breakthrough PainFAERS: 6US FAERS
56CryingFAERS: 6US FAERS
57Drug dispensing errorFAERS: 6US FAERS
58Drug effect incompleteFAERS: 6US FAERS
59FlushingFAERS: 6US FAERS
60HypophagiaFAERS: 6US FAERS
61Intentional product misuseFAERS: 6US FAERS
62Product use issueFAERS: 6US FAERS
63Respiratory DepressionFAERS: 6US FAERS
64Abdominal discomfortFAERS: 5US FAERS
65Altered state of consciousnessFAERS: 5US FAERS
66Blood glucose increasedFAERS: 5US FAERS
67Drug DependenceFAERS: 5US FAERS
68Drug diversionFAERS: 5US FAERS
69Drug screen false positiveFAERS: 5US FAERS
70Medication ErrorFAERS: 5US FAERS
71No adverse eventFAERS: 5US FAERS
72Unresponsive to stimuliFAERS: 5US FAERS
73UrticariaFAERS: 5US FAERS
74Wrong technique in drug usage processFAERS: 5US FAERS
75Burning sensationFAERS: 4US FAERS
76Depressed Level of ConsciousnessFAERS: 4US FAERS
77DysarthriaFAERS: 4US FAERS
78Euphoric moodFAERS: 4US FAERS
79Feeling jitteryFAERS: 4US FAERS
80HypersomniaFAERS: 4US FAERS
81Memory impairmentFAERS: 4US FAERS
82Mood swingsFAERS: 4US FAERS
83NervousnessFAERS: 4US FAERS
84NeuralgiaFAERS: 4US FAERS
85PancreatitisFAERS: 4US FAERS
86PneumoniaFAERS: 4US FAERS
87Respiratory FailureFAERS: 4US FAERS
88Visual ImpairmentFAERS: 4US FAERS
89AlopeciaFAERS: 3US FAERS
90AstheniaFAERS: 3US FAERS
91BedriddenFAERS: 3US FAERS
92BradyphreniaFAERS: 3US FAERS
93BronchospasmFAERS: 3US FAERS
94Depressed moodFAERS: 3US FAERS
95Disease ProgressionFAERS: 3US FAERS
96Drug screen negativeFAERS: 3US FAERS
97DysphoniaFAERS: 3US FAERS
98Emotional distressFAERS: 3US FAERS
99Erectile dysfunctionFAERS: 3US FAERS
100Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
101General physical health deteriorationFAERS: 3US FAERS
102Head discomfortFAERS: 3US FAERS
103Impaired work abilityFAERS: 3US FAERS
104Mental impairmentFAERS: 3US FAERS
105Restless Legs SyndromeFAERS: 3US FAERS
106Sinus TachycardiaFAERS: 3US FAERS
107Transaminases increasedFAERS: 3US FAERS
108Activities of daily living impairedFAERS: 2US FAERS
109Acute kidney injuryFAERS: 2US FAERS
110AkathisiaFAERS: 2US FAERS
111Angina PectorisFAERS: 2US FAERS
112Back PainFAERS: 2US FAERS
113BlindnessFAERS: 2US FAERS
114Blood alkaline phosphatase increasedFAERS: 2US FAERS
115BradycardiaFAERS: 2US FAERS
116Burning feet syndromeFAERS: 2US FAERS
117Cardiac ArrestFAERS: 2US FAERS
118Cardiac stress test abnormalFAERS: 2US FAERS
119ChillsFAERS: 2US FAERS
120CyanosisFAERS: 2US FAERS
121DehydrationFAERS: 2US FAERS
122DementiaFAERS: 2US FAERS
123DiscomfortFAERS: 2US FAERS
124DiverticulitisFAERS: 2US FAERS
125Dreamy stateFAERS: 2US FAERS
126Drug ToleranceFAERS: 2US FAERS
127Drug administered to patient of inappropriate ageFAERS: 2US FAERS
128Drug ineffective for unapproved indicationFAERS: 2US FAERS
129DyspepsiaFAERS: 2US FAERS
130ErythemaFAERS: 2US FAERS
131Facial PainFAERS: 2US FAERS
132FormicationFAERS: 2US FAERS
133Gastric BypassFAERS: 2US FAERS
134HypokinesiaFAERS: 2US FAERS
135ImmobileFAERS: 2US FAERS
136Impaired driving abilityFAERS: 2US FAERS
137Inadequate analgesiaFAERS: 2US FAERS
138IncoherentFAERS: 2US FAERS
139Intentional drug misuseFAERS: 2US FAERS
140Intentional product use issueFAERS: 2US FAERS
141Intentional self-injuryFAERS: 2US FAERS
142Medication residue presentFAERS: 2US FAERS
143Middle insomniaFAERS: 2US FAERS
144Myocardial InfarctionFAERS: 2US FAERS
145MyoclonusFAERS: 2US FAERS
146Nerve injuryFAERS: 2US FAERS
147Poor quality drug administeredFAERS: 2US FAERS
148Prescribed overdoseFAERS: 2US FAERS
149PresyncopeFAERS: 2US FAERS
150Product contaminationFAERS: 2US FAERS
151TachyarrhythmiaFAERS: 2US FAERS
152TensionFAERS: 2US FAERS
153Therapy changeFAERS: 2US FAERS
154TinnitusFAERS: 2US FAERS
155Urinary tract infectionFAERS: 2US FAERS
156Wrong drug administeredFAERS: 2US FAERS
157Wrong technique in product usage processFAERS: 2US FAERS
158Accidental exposureFAERS: 1US FAERS
159Accidental overdoseFAERS: 1US FAERS
160AgoraphobiaFAERS: 1US FAERS
161Alanine Aminotransferase IncreasedFAERS: 1US FAERS
162Altered visual depth perceptionFAERS: 1US FAERS
163AngerFAERS: 1US FAERS
164AngioedemaFAERS: 1US FAERS
165AnorgasmiaFAERS: 1US FAERS
166Anticholinergic SyndromeFAERS: 1US FAERS
167Anticoagulation drug level decreasedFAERS: 1US FAERS
168ArthritisFAERS: 1US FAERS
169Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
170AsphyxiaFAERS: 1US FAERS
171AtaxiaFAERS: 1US FAERS
172Atrial FibrillationFAERS: 1US FAERS
173Back disorderFAERS: 1US FAERS
174Bipolar DisorderFAERS: 1US FAERS
175Blood creatine phosphokinase MB increasedFAERS: 1US FAERS
176Blood glucose decreasedFAERS: 1US FAERS
177Blood magnesium decreasedFAERS: 1US FAERS
178Blood sodium decreasedFAERS: 1US FAERS
179Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
180Body temperature fluctuationFAERS: 1US FAERS
181Breath HoldingFAERS: 1US FAERS
182Breathing-related sleep disorderFAERS: 1US FAERS
183Carbon dioxide increasedFAERS: 1US FAERS
184ChondrosarcomaFAERS: 1US FAERS
185Cold sweatFAERS: 1US FAERS
186Coma scale abnormalFAERS: 1US FAERS
187Completed SuicideFAERS: 1US FAERS
188Conduct DisorderFAERS: 1US FAERS
189Cystic FibrosisFAERS: 1US FAERS
190Deep Vein ThrombosisFAERS: 1US FAERS
191Dental cariesFAERS: 1US FAERS
192DependenceFAERS: 1US FAERS
193DermatitisFAERS: 1US FAERS
194Diabetes MellitusFAERS: 1US FAERS
195Diabetes mellitus inadequate controlFAERS: 1US FAERS
196DiplegiaFAERS: 1US FAERS
197DisabilityFAERS: 1US FAERS
198DysuriaFAERS: 1US FAERS
199EmbolismFAERS: 1US FAERS
200Emotional disorderFAERS: 1US FAERS
201Extra dose administeredFAERS: 1US FAERS
202Eye opacityFAERS: 1US FAERS
203Feeling ColdFAERS: 1US FAERS
204Feeling of body temperature changeFAERS: 1US FAERS
205Fibrin D dimer increasedFAERS: 1US FAERS
206FibromyalgiaFAERS: 1US FAERS
207FlatulenceFAERS: 1US FAERS
208FractureFAERS: 1US FAERS
209FrustrationFAERS: 1US FAERS
210GastrectomyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
211Gastric ulcerFAERS: 1US FAERS
212GoutFAERS: 1US FAERS
213Hallucinations, mixedFAERS: 1US FAERS
214Heat StrokeFAERS: 1US FAERS
215HepatitisFAERS: 1US FAERS
216HepatotoxicityFAERS: 1US FAERS
217HyperkinesiaFAERS: 1US FAERS
218Hypertensive crisisFAERS: 1US FAERS
219HyperventilationFAERS: 1US FAERS
220Hypoaesthesia facialFAERS: 1US FAERS
221HypoxiaFAERS: 1US FAERS
222ImmunosuppressionFAERS: 1US FAERS
223Inappropriate schedule of product administrationFAERS: 1US FAERS
224Incorrect drug administration durationFAERS: 1US FAERS
225InfarctionFAERS: 1US FAERS
226InfectionFAERS: 1US FAERS
227InfluenzaFAERS: 1US FAERS
228Intercepted drug prescribing errorFAERS: 1US FAERS
229Intestinal ObstructionFAERS: 1US FAERS
230Limb injuryFAERS: 1US FAERS
231Lip swellingFAERS: 1US FAERS
232Living in residential institutionFAERS: 1US FAERS
233Loose toothFAERS: 1US FAERS
234Loss of personal independence in daily activitiesFAERS: 1US FAERS
235Lower respiratory tract infectionFAERS: 1US FAERS
236MalabsorptionFAERS: 1US FAERS
237Malignant genitourinary tract neoplasmFAERS: 1US FAERS
238Medical device implantationFAERS: 1US FAERS
239MeningitisFAERS: 1US FAERS
240Mental status changesFAERS: 1US FAERS
241Multiple SclerosisFAERS: 1US FAERS
242Musculoskeletal stiffnessFAERS: 1US FAERS
243MydriasisFAERS: 1US FAERS
244Nephrotic SyndromeFAERS: 1US FAERS
245NeutropeniaFAERS: 1US FAERS
246OliguriaFAERS: 1US FAERS
247Opiates negativeFAERS: 1US FAERS
248Oral painFAERS: 1US FAERS
249Oral pruritusFAERS: 1US FAERS
250Oropharyngeal discomfortFAERS: 1US FAERS
251Oropharyngeal spasmFAERS: 1US FAERS
252PallorFAERS: 1US FAERS
253Panic DisorderFAERS: 1US FAERS
254ParanoiaFAERS: 1US FAERS
255ParesisFAERS: 1US FAERS
256Peripheral swellingFAERS: 1US FAERS
257PneumothoraxFAERS: 1US FAERS
258PoisoningFAERS: 1US FAERS
259Poor quality product administeredFAERS: 1US FAERS
260Poor quality sleepFAERS: 1US FAERS
261Post-traumatic neck syndromeFAERS: 1US FAERS
262Postoperative deliriumFAERS: 1US FAERS
263Pre-existing condition improvedFAERS: 1US FAERS
264Product packaging issueFAERS: 1US FAERS
265Product physical issueFAERS: 1US FAERS
266Product residue presentFAERS: 1US FAERS
267Product shape issueFAERS: 1US FAERS
268Product storage errorFAERS: 1US FAERS
269Product use complaintFAERS: 1US FAERS
270Psychomotor skills impairedFAERS: 1US FAERS
271Pulmonary EmbolismFAERS: 1US FAERS
272Rash erythematousFAERS: 1US FAERS
273Respiratory arrestFAERS: 1US FAERS
274RetchingFAERS: 1US FAERS
275RhabdomyolysisFAERS: 1US FAERS
276Rotator cuff syndromeFAERS: 1US FAERS
277SepsisFAERS: 1US FAERS
278Sexual DysfunctionFAERS: 1US FAERS
279Sinus bradycardiaFAERS: 1US FAERS
280SneezingFAERS: 1US FAERS
281SomnambulismFAERS: 1US FAERS
282Spinal fusion surgeryFAERS: 1US FAERS
283StomatitisFAERS: 1US FAERS
284StridorFAERS: 1US FAERS
285StuporFAERS: 1US FAERS
286TachyphreniaFAERS: 1US FAERS
287Therapeutic agent urine negativeFAERS: 1US FAERS
288Therapeutic response delayedFAERS: 1US FAERS
289Therapeutic response unexpectedFAERS: 1US FAERS
290Therapy cessationFAERS: 1US FAERS
291ThirstFAERS: 1US FAERS
292Tongue bitingFAERS: 1US FAERS
293Urinary IncontinenceFAERS: 1US FAERS
294Uterine CancerFAERS: 1US FAERS
295Waist circumference increasedFAERS: 1US FAERS
296Weight decreasedFAERS: 1US FAERS
297YawningFAERS: 1US FAERS
298nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.